Pardoux C, Asselin-Paturel C, Chehimi J, Gay F, Mami-Chouaib F, Chouaib S
Laboratory of Cytokines and Antitumor Immunity, CJF 94-11 INSERM, Gustave Roussy Institute, Villejuif, France.
J Immunol. 1997 Jan 1;158(1):136-43.
IL-12 is an important cytokine in the control of cell-mediated immunity. We have investigated the functional interaction of IL-12 with TGF-beta1, a cytokine involved in the regulation of growth and differentiation of immunocompetent cells, during human allogeneic response development. Using primary MLR, our data show that addition of exogenous TGF-beta at the sensitizing phase of the primary MLR resulted in the inhibition of both allogeneic cytotoxic and proliferative responses. The inhibitory effect of TGF-beta on allogeneic response involves an abrogation of IL-12/p70 production upon allostimulation. In contrast to its effect on IL-12 production, TGF-beta did not alter the expression of IL-12R beta1-chain (IL-12R beta) in T cells induced upon allogeneic activation. Addition of exogenous IL-12 or IFN-gamma in the MLR cultures in the presence of TGF-beta did not result in reversal of CTL generation and T cell proliferation. Interestingly, TGF-beta was efficient in down-regulating IL-12 responsiveness of alloactivated T cells as well as TCR-alphabeta or TCR-gammadelta alloreactive T cell clones. These studies suggest that the inhibitory effect of TGF-beta on the development of human allogeneic proliferation and cytotoxic responses involves an additional mechanism associated with an interference with IL-12 pathway.
白细胞介素-12(IL-12)是控制细胞介导免疫的一种重要细胞因子。我们研究了在人类同种异体反应发展过程中,IL-12与转化生长因子-β1(TGF-β1,一种参与免疫活性细胞生长和分化调节的细胞因子)之间的功能相互作用。利用原发性混合淋巴细胞反应(MLR),我们的数据表明,在原发性MLR的致敏阶段添加外源性TGF-β会导致同种异体细胞毒性和增殖反应均受到抑制。TGF-β对同种异体反应的抑制作用涉及在同种异体刺激后消除IL-12/p70的产生。与其对IL-12产生的影响相反,TGF-β并未改变同种异体激活诱导的T细胞中IL-12Rβ1链(IL-12Rβ)的表达。在存在TGF-β的情况下,向MLR培养物中添加外源性IL-12或干扰素-γ并不会导致细胞毒性T淋巴细胞(CTL)生成和T细胞增殖的逆转。有趣的是,TGF-β能够有效下调同种异体激活的T细胞以及TCR-αβ或TCR-γδ同种异体反应性T细胞克隆的IL-12反应性。这些研究表明,TGF-β对人类同种异体增殖和细胞毒性反应发展的抑制作用涉及一种与干扰IL-12途径相关的额外机制。